Precursor Cell Lymphoblastic Leukemia-Lymphoma: all 2,121 studies
Page 12 of 22. Open to participants first (492), then studies with results posted, then the rest; newest registration first within each.
- Phase I Study of pCAR-19B in the Treatment of Adult CD19-positive Relapsed/Refractory B-ALLStatus unknownNCT04888442Phase 1
- A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow TransplantActive, not recruitingNCT04872595Phase 2
- A Study of Anti-CD7 CAR-T Cells in Pediatric and Young Adult Patients With Relapse and Refractory T-ALL/ T-LBLWithdrawnNCT04860817Early Phase 1
- Investigation of Remimazolam in Children Undergoing Sedation for Medical ProceduresActive, not recruitingNCT04851717Phase 2/3
- Regional Anesthesia for Totally Awake Upper Limb Surgery in PEDiatric PopulationCompletedNCT04846855Phase 4
- Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaWithdrawnNCT04845035Phase 2
- RPM CD19-mbIL15-CAR-T Cells in Patient With Advanced Lymphoid MalignanciesTerminatedNCT04844086Phase 1
- TDM of Asparaginase in ALL2008CompletedNCT04843514
- Pharmacokinetics and Immunogenicity of the First Doses of PEG-Asparaginase -An ALLTogether Pilot StudyCompletedNCT04843150
- Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell MalignanciesSuspendedNCT04828174Phase 1
- Post-thrombotic Syndrome After Deep Venous Thrombosis (DVT) in Patients Treated According to the NOPHO ALL2008 ProtocolCompletedNCT04825548
- Single and Multiple Ascending Dose Study With EP395CompletedNCT04819854Phase 1
- SPARK-ALL: Calaspargase Pegol in Adults With ALLTerminatedNCT04817761Phase 2/3
- Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell TumorsStatus unknownNCT04814004Phase 1
- Window Trial to Evaluate Molecular Response to PI3K Inhibition With Copanlisib in r/r Adult B-cell ALLTerminatedNCT04803123Early Phase 1
- Effects of the Face Mask on Physical Fitness in ChildrenCompletedNCT04800848
- Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological MalignanciesStatus unknownNCT04796688Phase 1
- Cord Blood Derived Anti-CD19 CAR-Engineered NK Cells for B Lymphoid MalignanciesStatus unknownNCT04796675Phase 1
- Senl-h19 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaStatus unknownNCT04792593Not applicable
- Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph+ B-ALLCompletedNCT04788472Phase 2
- CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PMLActive, not recruitingNCT04787263Phase 1/2
- ALL SCTped 2012 FORUM Add-on Study Blina Post HSCTTerminatedNCT04785547Phase 2
- Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to TherapyActive, not recruitingNCT04778579Phase 2
- Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic LeukemiaCompletedNCT04770922
- Induced-T Cell Like NK Cells for B Cell MalignanciesStatus unknownNCT04747093Phase 1/2
- Clinical Characteristics of Patients With Leukemia and COVID-19CompletedNCT04745416
- Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph- B-ALLStatus unknownNCT04740203Phase 1/2
- Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid MalignanciesActive, not recruitingNCT04732845Phase 1
- Dual Target CAR-T Cells in B-cell Acute Lymphoblastic LeukemiaStatus unknownNCT04723901Phase 1/2
- Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2019 PilotStatus unknownNCT04723342Not applicable
- Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALLActive, not recruitingNCT04722848Phase 3
- Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Acute B Lymphocytic LeukemiaStatus unknownNCT04714593Phase 1/2
- Efficacy of Intermediate and High Intensity Regimens in Patients With Relapsed Acute Lymphoblastic LeukemiaCompletedNCT04699162
- A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological MalignanciesCompletedNCT04689204Early Phase 1
- huCART19-IL18 in CD19+ CancersActive, not recruitingNCT04684563Phase 1
- the Efficacy and Safety of CLAE in R/R T-ALL/LBLStatus unknownNCT04679506
- Evaluation of Long-term Health Status and Quality of Life in Adult Survivors With Philadelphia-negative Acute Lymphoblastic Leukemia/Lymphoma Treated With an Intensive Pediatric or Pediatric-inspired ProtocolStatus unknownNCT04677231
- PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCTCompletedNCT04669210Phase 2
- SARS-CoV-2 Donor-Recipient Immunity TransferCompletedNCT04666025
- Effectiveness of Exercise Through Video Games in Reducing Fatigue Among Children With LeukemiaCompletedNCT04663516Not applicable
- CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)Status unknownNCT04653493Phase 1
- Hb A1C Pre and Post Confinement in Latin American Children With Type 1 Diabetes: Dulce Study GroupStatus unknownNCT04640064
- Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme TestCompletedNCT04635384
- Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCTCompletedNCT04629430Not applicable
- CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic LeukemiaStatus unknownNCT04626765Early Phase 1
- Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell TransplantationStatus unknownNCT04626726Early Phase 1
- RD13-01 for Patients With r/r CD7+ T-ALL/T-LBLStatus unknownNCT04620655Not applicable
- Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic LeukemiaActive, not recruitingNCT04606433Phase 1
- Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD)Status unknownNCT04604691Phase 1
- GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALLTerminatedNCT04601584Phase 1/2
- Anti-CD5 CAR T Cells for Relapsed/Refractory T Cell MalignanciesStatus unknownNCT04594135Phase 1
- Intraocular Pressure in Children With Acute Lymphoblastic Leukemia (ALL) Treated With High Dose SteroidsStatus unknownNCT04593745Not applicable
- Cell Therapy for CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD7-Specific CAR-T CellsCompletedNCT04572308Phase 1
- MAP to Provide Access to Nilotinib, for Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaNo longer availableNCT04559555
- TT52CAR19 Therapy for B-cell Acute Lymphoblastic Leukaemia (B-ALL)CompletedNCT04557436Phase 1
- Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL)CompletedNCT04554485Phase 2
- Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph+ ALLTerminatedNCT04554459Phase 2
- Assesment of JL1 Expression in Acute LeukemiaStatus unknownNCT04554381Phase 1
- Safety and Efficacy Study of CD22 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic LeukemiaStatus unknownNCT04546906Not applicable
- The clonoSEQ® Watch RegistryTerminatedNCT04545333
- Goal Management Training for Adult Survivors of Childhood Leukemia and Non-Hodgkins Lymphoma With Neurocognitive SequelaeActive, not recruitingNCT04541056Not applicable
- Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST StudyActive, not recruitingNCT04537871
- Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory LeukemiaTerminatedNCT04526795Phase 1
- A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALLActive, not recruitingNCT04521231Phase 1/2
- Vitamin D and Methotrexate Adverse EffectsStatus unknownNCT04488237
- Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDSActive, not recruitingNCT04482894Not applicable
- CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label StudyStatus unknownNCT04480788Phase 1
- Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological RelapseActive, not recruitingNCT04475731Phase 2
- Haplo Peripheral Blood Sct In GVHD PreventionCompletedNCT04473911Phase 1
- Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer SurvivorsCompletedNCT04472286
- HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell TransplantationWithdrawnNCT04464889Phase 1
- Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19CompletedNCT04452604
- Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALLWithdrawnNCT04448834Phase 2
- Study of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers PatientsStatus unknownNCT04446130Phase 3
- Preclinical Project on the Traitment of Acute Lymphoblastique Leukemia With NVP-BEP800, an Inhibitor of the Heat Shock Protein HSP90Status unknownNCT04437420
- Biology and Benefits of Music Play and Stories for Kids/Parents During ALL TreatmentCompletedNCT04400071Not applicable
- ETOILE : A Feasibility Study in Pediatric Patient EducationCompletedNCT04399863Not applicable
- Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALLStatus unknownNCT04375683Phase 3
- Correlation of Polymorphisms of Lipoprotein Lipase (LpL) and Apolipoprotein E (Apo E) With Lipid Profile of Children With Acute Lymphoblastic Eukaemia During Therapy With L - Asparaginase.Status unknownNCT04364451
- Study of Anti-CD22 CAR-T Cells Treating Leukemia ChildrenCompletedNCT04340167Phase 2
- Study of Sequential CAR-T Cell Treating Leukemia ChildrenTerminatedNCT04340154Phase 2
- Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaActive, not recruitingNCT04329325Phase 2
- Safety of Expanded Haploidentical Natural Killer Cells for LeukemiaCompletedNCT04327037Phase 1
- Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia ChildrenCompletedNCT04325841Phase 2
- TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic LeukemiaCompletedNCT04323657Phase 1/2
- Continuous Ambulatory Monitoring to Predict Elevated Risk of Infection in Children With Lymphoblastic Leukemia Undergoing Induction Chemotherapy (CAMPER-ALL)WithdrawnNCT04322084
- PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor DisabilityCompletedNCT04321200
- A Multicenter Prospective Study of "High Risk" Molecular Typing in Patients With Adult T Lymphoblastic LymphomaStatus unknownNCT04320992
- Anti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic LeukemiaStatus unknownNCT04289220Phase 1
- CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic MalignanciesWithdrawnNCT04282174Phase 2
- Overweight and Obesity as Prognostic Factors for Survival in Children With Acute Lymphoblastic LeukemiaStatus unknownNCT04271215
- Anti-CD19 U-CAR-T Cell Therapy for B Cell Hematologic MalignanciesStatus unknownNCT04264039Early Phase 1
- Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute LeukemiaActive, not recruitingNCT04262843Phase 2
- Impact of a Double-reading Animated Film (Child, Parents) in Preoperative on the Anxiety of Children Upon Arrival at the Operating RoomCompletedNCT04252508Not applicable
- The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I MutationCompletedNCT04233346Phase 2
- Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute LeukemiaActive, not recruitingNCT04232241Phase 2
- A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Acute Lymphoblastic LeukemiaCompletedNCT04230473Phase 1
- The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in ChinaStatus unknownNCT04228393Phase 2/3
- A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological MalignancyStatus unknownNCT04226989Early Phase 1
- CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in ChildrenCompletedNCT04224571Phase 2